BerandaVEEV • NYSE
add
Veeva Systems Inc
$285,36
Setelah Jam Perdagangan Normal:(0,13%)-0,36
$285,00
Tutup: 6 Jun, 18.52.16 GMT-4 · USD · NYSE · Pernyataan Penyangkalan
Tutup sebelumnya
$289,94
Rentang hari
$284,91 - $290,96
Rentang tahun
$176,41 - $291,68
Kapitalisasi pasar
46,50 M USD
Volume Rata-Rata
1,54 jt
Rasio P/E
60,54
Hasil dividen
-
Bursa utama
NYSE
Dalam berita
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Apr 2025info | Perubahan Y/Y |
---|---|---|
Pendapatan | 759,04 jt | 16,71% |
Biaya operasional | 351,49 jt | 11,13% |
Laba bersih | 228,19 jt | 41,15% |
Margin laba bersih | 30,06 | 20,92% |
Penghasilan per saham | 1,97 | 31,33% |
EBITDA | 243,55 jt | 44,40% |
Tarif pajak efektif | 23,64% | — |
Neraca
Total aset
Total liabilitas
(USD) | Apr 2025info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 6,07 M | 27,35% |
Total aset | 7,77 M | 25,50% |
Total liabilitas | 1,55 M | 19,70% |
Total ekuitas | 6,21 M | — |
Saham yang beredar | 163,41 jt | — |
Harga terhadap nilai buku | 7,61 | — |
Tingkat pengembalian aset | 7,74% | — |
Tingkat pengembalian modal | 9,58% | — |
Arus Kas
Perubahan kas bersih
(USD) | Apr 2025info | Perubahan Y/Y |
---|---|---|
Laba bersih | 228,19 jt | 41,15% |
Kas dari operasi | 877,16 jt | 14,88% |
Kas dari investasi | -52,11 jt | 80,87% |
Kas dari pembiayaan | 20,38 jt | 432,39% |
Perubahan kas bersih | 846,20 jt | 71,40% |
Arus kas bebas | 843,22 jt | 14,14% |
Tentang
Veeva Systems Inc. is an American cloud-computing company focused on pharmaceutical and life sciences industry applications. Headquartered in Pleasanton, California, it was founded in 2007 by Peter Gassner and Matt Wallach. It operates with software as a service in the life-science industry.
Veeva Systems Inc. went public on the New York Stock Exchange in October 2013. As of May 5, 2022, it has a market capitalization of US$27.5 billion.
On February 1, 2021, Veeva became a public benefit corporation. This made it the first publicly-traded company to convert to a public benefit corporation.
On December 1, 2022, Veeva announced it would not renew its Salesforce partnership when it expired in September 2025, choosing instead to migrate Veeva CRM onto its own Vault Platform. The decision ended a 15+ year collaboration that had given Veeva approximately 80% market share in the life sciences CRM space. Wikipedia
Didirikan
2007
Kantor pusat
Situs
Karyawan
7.291